Humana (HUM)

NYSE:HUM

HUM

Humana

RESEARCH TOOLSreports

Want to see HUM full AI Analyst Report?

Humana (HUM) Stock Forecast & Price Target

2,705 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Hold

7 Buy

11 Hold

2 Sell

Based on 20 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$254.39

▲(24.01% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $254.39 with a high forecast of $441.00 and a low forecast of $180.00. The average price target represents a 24.01% change from the last price of $205.14.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"175":"$175","442":"$442","241.75":"$241.8","308.5":"$308.5","375.25":"$375.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":441,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$441.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":254.38684210526313,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$254.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":180,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$180.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[175,241.75,308.5,375.25,442],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.63,249.58153846153846,265.5330769230769,281.4846153846154,297.43615384615384,313.3876923076923,329.33923076923077,345.29076923076923,361.2423076923077,377.19384615384615,393.1453846153846,409.0969230769231,425.04846153846154,{"y":441,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.63,235.2266801619433,236.82336032388662,238.42004048582996,240.01672064777327,241.61340080971658,243.2100809716599,244.80676113360323,246.40344129554654,248.00012145748985,249.59680161943317,251.1934817813765,252.79016194331982,{"y":254.38684210526313,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,233.63,229.5046153846154,225.37923076923076,221.25384615384615,217.12846153846152,213.00307692307692,208.8776923076923,204.75230769230768,200.62692307692308,196.50153846153847,192.37615384615384,188.25076923076924,184.12538461538463,{"y":180,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":252.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.793,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.574,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.317,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":300.046,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.684,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.839,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.183,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.835,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.254,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.333,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.95,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.63,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$441.00

Average Price Target$254.39

Lowest Price Target$180.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

George Hill

Deutsche Bank

$235→$441

Buy

114.98%

Upside

Upgraded

05/20/26

Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank

Ann Hynes

Mizuho Securities

$290→$335

Buy

63.30%

Upside

Reiterated

05/19/26

Humana price target raised to $335 from $290 at MizuhoHumana price target raised to $335 from $290 at Mizuho

Erin Wright

Morgan Stanley

$217→$301.35

Sell

46.90%

Upside

Assigned

05/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Pyxis Oncology (NASDAQ: PYXS) and Candel Therapeutics (NASDAQ: CADL)

Jessica Tassan

Piper Sandler

$182→$254

Hold

23.82%

Upside

Reiterated

05/13/26

Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler

John Ransom

Raymond James

$230→$260

Buy

26.74%

Upside

Reiterated

05/01/26

Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James

Lisa Gill

J.P. Morgan

$180→$214

Hold

4.32%

Upside

Reiterated

05/01/26

Humana (HUM) Gets a Hold from J.P. Morgan

Ryan Langston

TD Cowen

$173→$211

Hold

2.86%

Upside

Assigned

05/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$220→$270

Hold

31.62%

Upside

Reiterated

04/30/26

Humana price target raised to $270 from $220 at TruistHumana price target raised to $270 from $220 at Truist

Michael Wiederhorn

Oppenheimer

$250→$260

Buy

26.74%

Upside

Reiterated

04/30/26

Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer

A.J. Rice

UBS

$195→$262

Hold

27.72%

Upside

Assigned

04/30/26

Humana (HUM) Gets a Hold from UBS

Scott Fidel

Goldman Sachs

$158→$195

Sell

-4.94%

Downside

Reiterated

04/30/26

Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs

Stephen Baxter

Wells Fargo

$227

Hold

10.66%

Upside

Reiterated

04/30/26

Wells Fargo Remains a Hold on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

$210→$267

Hold

30.16%

Upside

Reiterated

04/30/26

Humana Kept at Hold as Analyst Raises Price Target to $267 Amid Margin-Rebuild Focus and Uncertain Medical Cost Trends

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)

Andrew Mok CFA

Barclays

$176→$180

Hold

-12.26%

Downside

Reiterated

04/30/26

Humana (HUM) Gets a Hold from Barclays

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

George Hill

Deutsche Bank

$235→$441

Buy

114.98%

Upside

Upgraded

05/20/26

Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank

Ann Hynes

Mizuho Securities

$290→$335

Buy

63.30%

Upside

Reiterated

05/19/26

Humana price target raised to $335 from $290 at MizuhoHumana price target raised to $335 from $290 at Mizuho

Erin Wright

Morgan Stanley

$217→$301.35

Sell

46.90%

Upside

Assigned

05/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Pyxis Oncology (NASDAQ: PYXS) and Candel Therapeutics (NASDAQ: CADL)

Jessica Tassan

Piper Sandler

$182→$254

Hold

23.82%

Upside

Reiterated

05/13/26

Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler

John Ransom

Raymond James

$230→$260

Buy

26.74%

Upside

Reiterated

05/01/26

Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James

Lisa Gill

J.P. Morgan

$180→$214

Hold

4.32%

Upside

Reiterated

05/01/26

Humana (HUM) Gets a Hold from J.P. Morgan

Ryan Langston

TD Cowen

$173→$211

Hold

2.86%

Upside

Assigned

05/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (NASDAQ: RNAC) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$220→$270

Hold

31.62%

Upside

Reiterated

04/30/26

Humana price target raised to $270 from $220 at TruistHumana price target raised to $270 from $220 at Truist

Michael Wiederhorn

Oppenheimer

$250→$260

Buy

26.74%

Upside

Reiterated

04/30/26

Humana price target raised to $260 from $250 at OppenheimerHumana price target raised to $260 from $250 at Oppenheimer

A.J. Rice

UBS

$195→$262

Hold

27.72%

Upside

Assigned

04/30/26

Humana (HUM) Gets a Hold from UBS

Scott Fidel

Goldman Sachs

$158→$195

Sell

-4.94%

Downside

Reiterated

04/30/26

Humana price target raised to $195 from $158 at Goldman SachsHumana price target raised to $195 from $158 at Goldman Sachs

Stephen Baxter

Wells Fargo

$227

Hold

10.66%

Upside

Reiterated

04/30/26

Wells Fargo Remains a Hold on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

$210→$267

Hold

30.16%

Upside

Reiterated

04/30/26

Humana Kept at Hold as Analyst Raises Price Target to $267 Amid Margin-Rebuild Focus and Uncertain Medical Cost Trends

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)

Andrew Mok CFA

Barclays

$176→$180

Hold

-12.26%

Downside

Reiterated

04/30/26

Humana (HUM) Gets a Hold from Barclays

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months

Michael WiederhornOppenheimer

Success Rate

25/39 ratings generated profit

Average Return

+3.04%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 64.10% of your transactions generating a profit, with an average return of +3.04% per trade.

1 Year

Justin LakeWolfe Research

Success Rate

9/14 ratings generated profit

Average Return

+10.58%

Copying Justin Lake's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +10.58% per trade.

2 Years

Michael WiederhornOppenheimer

Success Rate

30/39 ratings generated profit

Average Return

+13.62%

Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +13.62% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 10 Buy Ratings, 17 Hold Ratings, and 2 Sell Ratings. HUM average Analyst price target in the past 3 months is 254.39.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $6.83 with a range of $1.61 to $7.68. The previous quarter’s EPS was $10.31. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $40.56B with a range of $40.00B to $41.30B. The previous quarter’s sales results were $39.65B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana’s 12-month average price target is 254.39.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana has 24.01% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana has a consensus rating of Hold which is based on 7 buy ratings, 11 hold ratings and 2 sell ratings.

What is Humana’s price target?

The average price target for Humana is 254.39. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $441.00 ,the lowest forecast is $180.00. The average price target represents 24.01% Increase from the current price of $205.14.

What do analysts say about Humana?

Humana’s analyst rating consensus is a Hold. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Detailed List of Analyst Forecasts